News
PRVCF
0.010
NaN%
--
Weekly Report: what happened at PRVCF last week (0928-1002)?
Weekly Report · 3d ago
PreveCeutical Launches $600,000 Private Placement to Fund R&D and Corporate Costs
TipRanks · 09/28 22:04
PreveCeutical launches private placement to raise up to $600,000
Seeking Alpha · 09/28 21:16
PreveCeutical Announces Non-Brokered Private Placement
Newsfile · 09/28 21:00
Weekly Report: what happened at PRVCF last week (0921-0925)?
Weekly Report · 09/28 09:39
Weekly Report: what happened at PRVCF last week (0914-0918)?
Weekly Report · 09/21 09:39
Weekly Report: what happened at PRVCF last week (0907-0911)?
Weekly Report · 09/14 09:42
Weekly Report: what happened at PRVCF last week (0831-0904)?
Weekly Report · 09/07 09:38
Weekly Report: what happened at PRVCF last week (0824-0828)?
Weekly Report · 08/31 09:42
Weekly Report: what happened at PRVCF last week (0817-0821)?
Weekly Report · 08/24 09:42
Weekly Report: what happened at PRVCF last week (0810-0814)?
Weekly Report · 08/17 09:43
Weekly Report: what happened at PRVCF last week (0803-0807)?
Weekly Report · 08/10 09:40
PreveCeutical Closes Fourth Tranche of Non-Brokered Private Placement
Newsfile · 08/04 21:20
Weekly Report: what happened at PRVCF last week (0727-0731)?
Weekly Report · 08/03 09:40
PreveCeutical Closes Third Tranche of Non-Brokered Private Placement
Newsfile · 07/27 21:12
Weekly Report: what happened at PRVCF last week (0720-0724)?
Weekly Report · 07/27 09:42
Weekly Report: what happened at PRVCF last week (0713-0717)?
Weekly Report · 07/20 09:40
Weekly Report: what happened at PRVCF last week (0706-0710)?
Weekly Report · 07/13 09:41
Weekly Report: what happened at PRVCF last week (0629-0703)?
Weekly Report · 07/06 09:43
Weekly Report: what happened at PRVCF last week (0622-0626)?
Weekly Report · 06/29 09:41
More
Webull provides a variety of real-time PRVCF stock news. You can receive the latest news about Preveceutical through multiple platforms. This information may help you make smarter investment decisions.
About PRVCF
PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, and BSV Peptide Program. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury). Its Nature Identical peptides used for treatment of various ailments. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity.